Sandbox fungal meningitis: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
No edit summary
ShiSheng (talk | contribs)
No edit summary
Line 88: Line 88:
<div class="mw-collapsible mw-collapsed">
<div class="mw-collapsible mw-collapsed">


===Coccidioides===
===Coccidioides<ref name="pmid16206093">Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA et al. (2005) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16206093 Coccidioidomycosis.] ''Clin Infect Dis'' 41 (9):1217-23. [http://dx.doi.org/10.1086/496991 DOI:10.1086/496991] PMID: [http://pubmed.gov/16206093 16206093]</ref>===


<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 173: Line 173:


</div></div>
</div></div>
==Viral Meningitis==
{|
|-
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:39em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|[[Herpes simplex Meningitis]]}}''
|-
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen''
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Aciclovir]]''''' IV  <BR>''OR''<BR>▸ '''''[[Valaciclovir]]'''''PO
|-
|}
|}





Revision as of 18:32, 20 January 2014

Meningitis Main Page

Patient Information

Overview

Causes

Classification

Viral Meningitis
Bacterial Meningitis
Fungal Meningitis

Differential Diagnosis

Diagnosis

Treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Sheng Shi, M.D. [2]


fungal meningitis

Blastomyces

Blastomyces
Preferred Regimen
Liposomal amphotericin B 5 mg/kg/day IV for 4–6 weeks
Followed By
Fluconazole 800 mg/day PO
OR
Itraconazole 200 mg PO bid or tid
OR
Voriconazole 200–400 mg IV q12h


Candidiasis

Candidiasis
Preferred Regimen
lipid-based ampho B 3–5 mg/kg/day
PLUS OR NOT
5-Fluorocytosine 25 mg/kg PO qid
Alternative Regimen
Fluconazole 400–800 mg (6–12 mg/kg) IV or PO


Histoplasma

Histoplasma
Preferred Regimen
Liposomal ampho B 5 mg/kg/d, for a total of 175 mg/kg over 4-6 wk
Followed By
Itraconazole 200 mg/day PO bid or tid for at least 12 month


Coccidioides[1]

Coccidioides
Preferred Regimen
FLuconazole 400 mg/day PO
OR
Itraconazole 400–600 mg/day PO


Cryptococcus HIV/AIDS[2]

Cryptococcus, HIV/AIDS
Induction Phrase(for 2 wks)
Amphotericin B deoxycholate 0.7 mg/kg/day IV
PLUS
5-Fluorocytosine 100 mg/kg/day PO
Consolidation phase(for 8 wks)
Fluconazole 400 mg/day PO
OR
Itraconazole 400 mg/day PO
Maintenance phase
Fluconazole 200 mg/day PO


Cryptococcus Immunocompetent[3]

Cryptococcus, Immunocompetent
Induction Phrase(for 2 wks)
Amphotericin B 0.7-1 mg/kg/day IV
OR
Liposomal amphotericin B 5 mg/kg/day PO
PLUS
5-Fluorocytosine 25 mg/kg PO q6h
Consolidation phase(for 8 wks)
Fluconazole 400 mg/day PO qd
Maintenance phase(for 12 mo)
Fluconazole 200 mg PO qd



Viral Meningitis

Herpes simplex Meningitis
Preferred Regimen
Aciclovir IV
OR
ValaciclovirPO



References

  1. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA et al. (2005) Coccidioidomycosis. Clin Infect Dis 41 (9):1217-23. DOI:10.1086/496991 PMID: 16206093
  2. Antinori S (2013) New Insights into HIV/AIDS-Associated Cryptococcosis. ISRN AIDS 2013 ():471363.http://dx.doi.org/10.1155/2013/471363 DOI:10.1155/2013/471363] PMID: 24052889
  3. Jackson A, van der Horst C (2012) New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep 9 (3):267-77. DOI:10.1007/s11904-012-0127-7 PMID: 22763808